Broker Ratings

AptarGroup, Inc. – Consensus ‘none’ rating and 19.3% Upside Potential

AptarGroup, Inc. which can be found using ticker (ATR) have now 6 confirmed analysts covering the stock with the consensus suggesting a rating of ‘none’. The target price High/Low ranges between $215.00 and $164.00 calculating the mean target price we have $186.17. Given that the stocks previous close was at $156.09 and the analysts are correct then there would likely be a percentage uptick in value of 19.3%. There is a 50 day moving average of $165.10 and the 200 day moving average is $153.59. The company has a market cap of 10.64B. The price for the stock stands currently at: $159.83 USD

The potential market cap would be $12,684,971,887 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 32.03, revenue per share of $54.01 and a 7.01% return on assets.

AptarGroup, Inc. is a designer and manufacturer of a range of drug delivery and consumer product dispensing, sealing and active packaging solutions and services. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma includes operations that sells dispensing systems and sealing solutions and also manufactures and sells elastomeric primary packaging components. The Company’s products include stoppers for infusion, antibiotic, lyophilization and diagnostic vials. The Aptar Beauty segment includes operations that sell dispensing systems, drug delivery systems, sealing solutions and services to the prescription drug, consumer health care, injectables, and active material science solutions markets. The Aptar Closures business serves multiple markets, including food, beverage, personal care, home care, beauty and healthcare. This segment offers food protection business and elastomeric flow-control technology business.

Share on:
Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

    AptarGroup, Inc. (ATR) Stock Analysis: Exploring a 36% Potential Upside with Solid Analyst Ratings

    Investors seeking opportunities within the healthcare sector’s medical instruments and supplies industry may find AptarGroup, Inc. (NYSE: ATR) an intriguing prospect. With a market capitalization of $8.49 billion, this U.S.-based

    AptarGroup, Inc. (ATR) Stock Analysis: Strong Buy Ratings and 35.85% Potential Upside

    AptarGroup, Inc. (NYSE: ATR) is capturing the attention of investors with its solid position in the healthcare sector, specifically within the medical instruments and supplies industry. As a leading designer

    AptarGroup, Inc. (ATR) Investor Outlook: Strong Buy Ratings and 34% Upside Potential

    AptarGroup, Inc. (NYSE: ATR) is making waves in the Healthcare sector, specifically within the Medical Instruments & Supplies industry. With a robust market capitalization of $8.63 billion, this Crystal Lake,

    AptarGroup, Inc. (ATR) Stock Analysis: Exploring a Potential 32.76% Upside for Investors

    AptarGroup, Inc. (NYSE: ATR) is making waves in the healthcare sector with its diversified portfolio of drug delivery and consumer product dispensing solutions. Headquartered in Crystal Lake, Illinois, AptarGroup serves

    AptarGroup, Inc. (ATR) Stock Analysis: Discover Its 33.69% Potential Upside

    AptarGroup, Inc. (NYSE: ATR), a leading player in the healthcare sector, specifically within the Medical Instruments & Supplies industry, has been capturing investor attention with a market cap of $8.72

    AptarGroup, Inc. (ATR) Stock Report: Analyzing a 33.69% Upside Potential for Investors

    AptarGroup, Inc. (NYSE: ATR), a prominent player in the healthcare sector, stands out within the medical instruments and supplies industry. With a robust market capitalization of $8.72 billion, the company

      Search

      Search